ChemoMetec

Historical price data

ChemoMetec's mission is to eliminate human error and variability from critical cell analysis workflows through automated, precision instrumentation. The company has achieved a dominant position in the GMP-compliant cell counting market, underpinned by its Danish engineering and a razor-and-blades consumables model. Its strategy focuses on penetrating high-growth segments like cell and gene therapy and bioprocessing, leveraging regulatory-ready platforms to drive exponential growth and become the number one provider in its field.

Automated, image-based cell counting and analysis platforms (NucleoCounter®, XcytoMatic®) utilizing proprietary disposable cassettes to deliver consistent, GMP-ready data while eliminating human error and hazardous reagents.

Competes with providers of automated cell counters (e.g., DeNovix, Bio-Rad, Thermo Fisher) and image cytometers. Key advantages are its regulatory-first design (21 CFR Part 11-ready), superior consumable ecosystem, and reputation for precision and reliability in GMP environments.